Analysis of data expected in early 2019 for CPP’s pivotal Phase 3 trial of CPP-1X/sul for adults with familial adenomatous polyposis (FAP), a rare genetic disease that, if left untreated, progresses to colorectal cancer in nearly 100% of patients.Continue reading→

Easy, accurate & affordable test for earlier colorectal cancer detection now available in ArizonaContinue reading→

A tax credit approved by the Arizona Legislature to incentivize investment in early-stage bioscience and technology companies has proven to be a popular tool among local funders.Continue reading→

 UA Cancer Center opens clinical trial in Greater Phoenix for novel liver cancer treatment.Continue reading→

Pre-Loaded Regenerative Medicine Syringe Saves Doctors Time and MoneyContinue reading→

New UA/Banner Health Valley Fever Clinical Guidelines to Help Avoid Delays in Diagnosis
Banner Health has launched new clinical practice protocols developed with input from the University of Arizona Valley Fever Center for Excellence to help physicians more quickly diagnose and treat patients with Valley fever infections.Continue reading→

A research team led by Jared Churko, PhD, director of the University of Arizona iPSC Core in the UA Sarver Heart Center, used a transcriptomic approach – studying what genes are expressed – to identify gene signatures of cell subpopulations identified as atrial-like or ventricular-like. This understanding could lead to regenerative therapy discoveries for the millions of people living with damaged heart muscle caused by heart attacks or other chronic heart conditions. Continue reading→

Michael Kruer, MD, receives the first federally funded grant to research genetic causes of condition that affects 1 in 250 children.Continue reading→